Zimmer Biomet Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZBH research report →
Companywww.zimmerbiomet.com
Zimmer Biomet Holdings, Inc. , together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.
- CEO
- Ivan Tornos
- IPO
- 2001
- Employees
- 17,000
- HQ
- Warsaw, IN, US
Price Chart
Valuation
- Market Cap
- $16.83B
- P/E
- 22.29
- P/S
- 2.00
- P/B
- 1.15
- EV/EBITDA
- 10.82
- Div Yield
- 1.10%
Profitability
- Gross Margin
- 70.03%
- Op Margin
- 15.61%
- Net Margin
- 9.05%
- ROE
- 5.78%
- ROIC
- 4.98%
Growth & Income
- Revenue
- $8.23B · 7.20%
- Net Income
- $705.20M · -21.97%
- EPS
- $3.56 · -20.00%
- Op Income
- $1.36B
- FCF YoY
- 28.87%
Performance & Tape
- 52W High
- $108.29
- 52W Low
- $79.12
- 50D MA
- $88.89
- 200D MA
- $94.21
- Beta
- 0.47
- Avg Volume
- 2.26M
Get TickerSpark's AI analysis on ZBH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 1, 26 | Stellato Paul A | other | 9,232 |
| Apr 1, 26 | Noor Jehanzeb | other | 6,626 |
| Apr 1, 26 | Noor Jehanzeb | other | 6,626 |
| Apr 1, 26 | Noor Jehanzeb | other | 1,677 |
| Mar 31, 26 | Jafry Syed A. | other | 182.421 |
| Mar 31, 26 | Kolli Sreelakshmi | other | 175.404 |
| Mar 31, 26 | Shapiro Louis | other | 154.356 |
| Mar 31, 26 | Hilado Maria Teresa | other | 378.873 |
| Mar 31, 26 | HIGGINS ARTHUR J | other | 308.711 |
| Mar 31, 26 | Kurdikar Devdatt | other | 154.356 |
Our ZBH Coverage
We haven't published any research on ZBH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ZBH Report →